Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Nonalcoholic Steatohepatitis (NASH) · Amyotrophic Lateral Sclerosis · CORT

CORCEPT THERAPEUTICS

CORCEPT THERAPEUTICS INC

CORCEPT THERAPEUTICS clinical programs — 35 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
101 Redwood Shores Pkwy, Redwood City, California 94065, US HQ
1998 Founded
756 Employees
Public company Type
CORT · NYSE Ticker
Company details
Status
Public
HQ
101 Redwood Shores Pkwy, Redwood City, California 94065, US
Founded
1998
Employees
756
Programs
67
Drugs
36
Patents
120
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

CORCEPT THERAPEUTICS projects

35 ClinicalTrials.gov programs sponsored by CORCEPT THERAPEUTICS.

CORCEPT THERAPEUTICS has 35 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

35 programs

Clinical programs

  1. 14C-CORT125281

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  2. CORT113176

    CORCEPT THERAPEUTICS INC

    Healthy Adults

    phase 1 small molecule completed

    1 trial

  3. CORT113176 Lipid Capsule Formulation

    CORCEPT THERAPEUTICS INC

    Healthy Adults

    phase 1 small molecule completed

    1 trial

  4. CORT118335 Oral

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  5. CORT118335, 25 mg

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  6. CORT125134

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    2 trials

  7. CORT125134 150 mg

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  8. CORT125236

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  9. CORT125281-600

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  10. CORT125329 lipid capsule formulation

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  11. Dabigatran Etexilate

    CORCEPT THERAPEUTICS INC

    Cushing Syndrome

    phase 1 small molecule completed

    1 trial

  12. Dazucorilant

    CORCEPT THERAPEUTICS INC

    Healthy Adults

    phase 1 small molecule completed

    1 trial

  13. Dazucorilant

    CORCEPT THERAPEUTICS INC

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  14. Enzalutamide

    CORCEPT THERAPEUTICS INC

    Prostate Cancer

    phase 1 small molecule completed

    1 trial

  15. Midazolam hydrochloride

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  16. Mifepristone

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  17. Mifepristone 300 MG

    CORCEPT THERAPEUTICS INC

    Drug Interaction Potentiation

    phase 1 small molecule completed

    1 trial

  18. Mifepristone and Eribulin in combination

    CORCEPT THERAPEUTICS INC

    Breast Cancer

    phase 1 small molecule completed

    1 trial

  19. Miricorilant

    CORCEPT THERAPEUTICS INC

    Non-alcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  20. Miricorilant

    CORCEPT THERAPEUTICS INC

    Antipsychotic Induced Weight Gain

    phase 1 small molecule completed

    1 trial

  21. Miricorilant 150 mg

    CORCEPT THERAPEUTICS INC

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  22. Miricorilant 300 mg tablets

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  23. Miricorilant Treatment A

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  24. Olanzapine

    CORCEPT THERAPEUTICS INC

    Antipsychotic-induced Weight Gain

    phase 1 small molecule completed

    1 trial

  25. Relacorilant

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  26. Relacorilant

    CORCEPT THERAPEUTICS INC

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  27. Relacorilant

    CORCEPT THERAPEUTICS INC

    Adrenocortical Carcinoma

    phase 1 small molecule completed

    1 trial

  28. Relacorilant (3x100 mg softgel capsules)

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  29. Relacorilant 350mg

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  30. Relacorilant Fasted

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  31. Relacorilant under fasted conditions

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  32. Risperidone

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  33. [14C]-CORT113176

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  34. [14C]-CORT125134

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  35. mifepristone + fluvastatin

    CORCEPT THERAPEUTICS INC

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does CORCEPT THERAPEUTICS have?

35 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.